CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Gregor Cuzak

  • Clinicians
  • Pacients
  • Researchers
  • Business Model
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
8 July 2024

The Promise and Price of Advanced Therapies

Here’s what Claude Sonnet 3.5 has to answer when we question it: why do ATMPs cost so much? Advanced Therapy Medicinal Products (ATMPs), including gene and cell therapies, represent a revolutionary frontier in medicine, ...

Firefly High Cost Medicinal Treatment, In Blue To White; Syringe And Money 24649
  • Events
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Clinic study
  • Marketaccess
  • Regulation
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • UMCUtrecht
  • Gregor Cuzak
1 July 2024

Panel Discussion on ATMP Regulation

The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ...

  • Interview
  • Researchers
  • Datamanagement
  • Drug Discovery
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
27 June 2024

Interview with Shivang Khandewal – collaborator of NIC and CTNNB1

Originally from India, Shivang Khandelwal is presently engaged in advanced studies at the Hebrew University of Jerusalem. His primary research focus is on PCDH19 cluster epilepsy, a neurodevelopmental and neuropsychiatric disorder. He is deeply ...

Shivang Khandelwal
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Drug Discovery
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
27 June 2024

Bespoke Gene Therapy Consortium – cooperation for rare disease therapies

At the Bespoke Gene Therapy Consortium (BGTC, website), a consortium for the treatment of rare monogenetic diseases, they aim to treat neglected diseases with a very small number of patients with a focus solely ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Gen Therapy
  • GMP
  • Clinic study
  • Datamanagement
  • Drug Discovery
  • Ethicalcommittee
  • Investment
  • Laboratory
  • Logistics
  • Manufacturing Process
  • Modalitetadelovanjazdravila
  • Pharmacodynamics
  • Pharmacokinetics
  • Pre Clinical
  • Raw Material
  • Regulation
  • Research
  • CTGCT
  • NIC
  • Gregor Cuzak
26 June 2024 Event Date: 14 June 2024 • 09:00 − 17:00

CTNNB1 Conference – One Year to Cure

One year to cure is the goal shared by parents of children with the CTNNB1 Syndrome rare disease. Out of approximately 400 known cases worldwide, 82 families with children gathered at the conference in ...

  • Articles
  • Events
  • Researchers
  • Economics
  • Investment
  • CTGCT
  • Gregor Cuzak
9 September 2023

TV Slovenija: Scientific development of advanced treatments

Science and Technology is RTV's news programme, offering viewers a weekly round-up of the most interesting events and news in the field of science and technology every Thursday, with in-depth features and analysis, guest ...

Posts pagination

1 2

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna